EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection

Wei Li iD, Kate Quigley

Biochemical Society Transactions · 26.06.2024 · 52 (3) · 1515-1528

DOI: 10.1042/bst20231547 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, online erschienen am 08.05.2024. Verfasst von Wei Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: VPD Heart and Lung Research Institute, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0BB, U.K. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein Receptors, Type II, Signal Transduction, Bone Morphogenetic Proteins, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial hypertension (PAH) is a rare and life-threatening vascular disorder, characterised by abnormal remodelling of the pulmonary vessels and elevated pulmonary artery pressure, leading to right ventricular hypertrophy and right-sided heart failure. The importance of bone morphogenetic protein (BMP) signalling in the pathogenesis of PAH is demonstrated by human genetic studies. Many PAH risk genes are involved in the BMP signalling pathway and are highly expressed or preferentially act on vascular endothelial cells. Endothelial dysfunction is recognised as an initial trigger for PAH, and endothelial BMP signalling plays a crucial role in the maintenance of endothelial integrity. BMPR2 is the most prevalent PAH gene, found in over 80% of heritable cases. As BMPRII protein is the major type II receptor for a large family of BMP ligands and expressed ubiquitously in many tissues, dysregulated BMP signalling in other cells may also contribute to PAH pathobiology. Sotatercept, which contains the extracellular domain of another transforming growth factor-β family type II receptor ActRIIA fused to immunoglobin Fc domain, was recently approved by the FDA as a treatment for PAH. Neither its target cells nor its mechanism of action is fully understood. This review will revisit BMPRII function and its extracellular regulation, summarise how dysregulated BMP signalling in endothelial cells and smooth muscle cells may contribute to PAH pathogenesis, and discuss how novel therapeutics targeting the extracellular regulation of BMP signalling, such as BMP9 and Sotatercept, can be related to restoring BMPRII function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Morphogenetic Protein Receptors, Type IISignal TransductionBone Morphogenetic ProteinsPulmonary Arterial HypertensionHumansAnimalsEndothelial Cells

Stichwörter der Autor:innen

BMP signallingcardiovascular diseaseextracellular regulation of signallingmolecular mechanismspulmonary arterial hypertensiontherapeutics

Substanzen

Bone Morphogenetic Protein Receptors, Type IIBone Morphogenetic ProteinsBMPR2 protein, human

Autor:innen und Institutionen

  • VPD Heart and Lung Research Institute, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0BB, U.K.

ORCID-Profile: Wei Li

Zitieren

APA

Li, W., & Quigley, K. (2024). Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection. Biochemical Society Transactions, 52(3), 1515-1528. https://doi.org/10.1042/bst20231547

Vancouver

Li W, Quigley K. Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection. Biochemical Society Transactions. 2024;52(3):1515-1528. doi:10.1042/bst20231547

BibTeX
@article{Li2024,
  author = {Li, Wei and Quigley, Kate},
  title = {Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection},
  journal = {Biochemical Society Transactions},
  year = {2024},
  volume = {52},
  number = {3},
  pages = {1515--1528},
  doi = {10.1042/bst20231547}
}
Kostenlos starten →